The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126664982 12666498 2 F 20160805 20160819 20160819 EXP US-CIPLA LTD.-2016US08309 CIPLA WARREN MB. VENLAFAXINE-ASSOCIATED EUPROLACTINEMIC GALACTORRHEA AND HYPERSEXUALITY: A CASE REPORT AND REVIEW OF THE LITERATURE. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2016;36 (4):399 TO 400 0.00 Y 0.00000 20160819 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126664982 12666498 1 SS ESCITALOPRAM ESCITALOPRAM OXALATE 1 Unknown UNK Y U 0
126664982 12666498 2 SS ESCITALOPRAM ESCITALOPRAM OXALATE 1 Y U 0
126664982 12666498 3 PS SERTRALINE SERTRALINE HYDROCHLORIDE 1 Unknown UNK Y U 77162
126664982 12666498 4 SS SERTRALINE SERTRALINE HYDROCHLORIDE 1 Y U 77162
126664982 12666498 5 SS VENLAFAXINE VENLAFAXINE HYDROCHLORIDE 1 Unknown 75 MG, QD Y U 0 75 MG QD
126664982 12666498 6 SS VENLAFAXINE VENLAFAXINE HYDROCHLORIDE 1 Unknown 37.5 MG, QD Y U 0 37.5 MG QD
126664982 12666498 7 SS BUSPIRONE BUSPIRONE HYDROCHLORIDE 1 Unknown UNK Y U 0
126664982 12666498 8 SS BUSPIRONE BUSPIRONE HYDROCHLORIDE 1 Y U 0
126664982 12666498 9 SS PAROXETINE. PAROXETINE 1 Unknown UNK Y U 0
126664982 12666498 10 SS PAROXETINE. PAROXETINE 1 Y U 0
126664982 12666498 11 C CLONAZEPAM. CLONAZEPAM 1 Unknown 0.25 MG, PRN U U 0 .25 MG
126664982 12666498 12 C FEXOFENADINE FEXOFENADINEFEXOFENADINE HYDROCHLORIDE 1 Unknown UNK U U 0
126664982 12666498 13 C Pseudoephedrine PSEUDOEPHEDRINE 1 Unknown UNK U U 0
126664982 12666498 14 C FLUTICASONE FLUTICASONEFLUTICASONE PROPIONATE 1 Unknown UNK U U 0
126664982 12666498 15 C ALBUTEROL. ALBUTEROL 1 Unknown UNK U U 0
126664982 12666498 16 C Budesonide/Formoterol BUDESONIDEFORMOTEROL 1 Unknown UNK U U 0
126664982 12666498 17 C OMEPRAZOLE. OMEPRAZOLE 1 Unknown UNK U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126664982 12666498 1 Depression
126664982 12666498 2 Anxiety
126664982 12666498 3 Depression
126664982 12666498 4 Anxiety
126664982 12666498 5 Depression
126664982 12666498 6 Panic attack
126664982 12666498 7 Depression
126664982 12666498 8 Anxiety
126664982 12666498 9 Depression
126664982 12666498 10 Anxiety
126664982 12666498 11 Panic attack
126664982 12666498 12 Hypersensitivity
126664982 12666498 13 Hypersensitivity
126664982 12666498 14 Hypersensitivity
126664982 12666498 15 Hypersensitivity
126664982 12666498 16 Hypersensitivity
126664982 12666498 17 Gastrooesophageal reflux disease

Outcome of event

Event ID CASEID OUTC COD
126664982 12666498 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126664982 12666498 Breast pain
126664982 12666498 Condition aggravated
126664982 12666498 Drug ineffective
126664982 12666498 Galactorrhoea
126664982 12666498 Hypersexuality
126664982 12666498 Vision blurred

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found